Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Abdom Imaging. 2014 Oct;39(5):1027–1035. doi: 10.1007/s00261-014-0136-7

Figure 1.

Figure 1

A 60-year-old man with Gleason 3 + 3 prostate cancer, clinical stage T1c, PSA of 8.4 ng/mL. Follow-up transrectal ultrasound-guided biopsy performed 1 year after this MRI was negative. A T2-weighted MRI shows a faint, wedge shaped, focus of low T2 signal in the peripheral zone of the right midgland gland (arrow). No corresponding abnormality was seen on B diffusion-weighted MRI or C MR spectroscopic imaging.